title: Endothelin-1 increased immunoreactive von Willebrand factor in endothelial cells and induced micro thrombosis in rats.
abstract: This study was performed (i) to investigate the interaction between ET-1 and endothelial cells and (ii) to study the role of ET-1 in in vivo thrombosis. Fura-2AM loaded human umbilical endothelial cell cultures were incubated with 0, 25, 50 and 100 pmol of ET-1 for 24 hours (n = 6) at 37 degrees C. Fura-2 released in the media was measured by spectroflurophotometer at wavelength of 350 nm excitation and 500 nm emission. We found significant (p < 0.01) and dose dependent decrease in Fura-2 release by the cells indicating increased intracellular calcium in HUVEC. Increased calcium by ET-1 was also confirmed at single cell level by fluorescence digital image analysis using Fura-2AM. 5 ml solution of ET-1 (100 pmol/ml) was injected within the venous lumen of umbilical cords (of normal pregnancy) clumped at both ends and incubated at a temperature 37 degrees C for 3 hours (n = 7). We found intensely stained immunoreactive von Willebrand factor (vWF) on the endothelial cells of ET treated umbilical cords when compared with sham control (Umbilical cords incubated with phosphate buffer saline; n = 7). Intravenous ET-1 infusions at a rate of 1 nmol/kg/hour for 2 hours (cases, n = 7) and 5% dextrose infusions (sham control, n = 7) were performed in rats. Aorta, kidney and liver tissues were obtained to perform immunostaining with polyclonal antibody to vWF and fibrinogen. ET-1 treated rat tissues showed intense staining for vWF and fibrinogen intravascularly at hte same site.(ABSTRACT TRUNCATED AT 250 WORDS)
authors: Department of Obstetrics and Gynaecology, University School of Medicine, Japan.
authors: A
authors: A
authors: Halim
authors: N
authors: N
authors: Kanayama
authors: E
authors: E
authors: el Maradny
authors: K
authors: K
authors: Maehara
authors: H
authors: H
authors: Masahiko
authors: T
authors: T
authors: Terao
mesh_terms: D000818:Animals; D000906:Antibodies; D001011:Aorta / Q000187:drug effects / Q000473:pathology; D002478:Cells, Cultured; D016232:Endothelins / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D013927:Thrombosis / Q000139:chemically induced; D014470:Umbilical Cord / Q000187:drug effects / Q000378:metabolism; D014841:von Willebrand Factor / Q000096:biosynthesis* / Q000276:immunology
chemical_list: D000906:Antibodies; D016232:Endothelins; D014841:von Willebrand Factor